Clinical Trials Directory

Trials / Completed

CompletedNCT01769612

Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia

Evaluation of a Diagnostic Device, CL Detect Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia

Status
Completed
Phase
Study type
Observational
Enrollment
168 (actual)
Sponsor
U.S. Army Medical Research and Development Command · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate the sensitivity and specificity of CL Detect, in subjects with suspected CL in Tunisia.

Detailed description

Subjects were selected based on clinical appearance of the skin lesion characteristics of cutaneous leishmaniasis (CL). Study compared the CL Detect Rapid Test vs microscopic identification of Leishmania amastigotes in a stained lesion sample. Two diagnostic samples were collected from the subjects lesion in the following order: 1) obtained with a dental broach for use with the CL Detect Rapid Test and 2) a second sample was obtained by scraping for use in the microscopic identification of amastigotes. Samples were analyzed by microscopy and CL Detect Repaid Test by different operators who evaluated each sample independently blinded to the other assay result.

Conditions

Interventions

TypeNameDescription
OTHERNo Intervention

Timeline

Start date
2013-01-01
Primary completion
2013-08-01
Completion
2014-04-01
First posted
2013-01-16
Last updated
2017-06-20
Results posted
2017-06-20

Locations

2 sites across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT01769612. Inclusion in this directory is not an endorsement.